Given that pharmacological modulation of the TRP ion channel activity in cancer cells is linked to their sensitivity to chemotherapeutic drugs [31], our goal was to examine the TRPML2 expression in GSCs and its relationship to resistance to TMZ, the standard chemotherapy for newly diagnosed GBM since 2005 and the subsequent use of the Stupp regimen [32]. This evidence concerns the gene MCOLN2 and cancer.